Literature DB >> 21438097

Comparative analysis of the expression of metalloproteases and their inhibitors in resected crohn's disease and complicated diverticular disease.

Antonio Altadill1, Noemí Eiró, Luis Ovidio González, Sara Junquera, José Manuel González-Quintana, María Rosario Sánchez, Alejandro Andicoechea, Cristina Saro, Luis Rodrigo, Francisco José Vizoso.   

Abstract

BACKGROUND: Matrix metalloproteinases (MMPs) and their inhibitors (TIMPs), are expressed in the gastrointestinal tract by different cellular types. Nevertheless, the imbalance between MMPs and TIMPs plays an important role in the physiopathology of diverse intestinal inflammatory processes.
METHODS: An immunohistochemical study was performed using tissue arrays and specific antibodies against MMPs -1, -2, -7, -9, -11, -13, -14, and TIMPs -1, -2 and -3. Immunohistochemical staining of intestinal samples from surgical interventions from 30 patients with complicated Crohn's disease (CD) and 25 patients with diverticulitis were performed at the inflamed mucosa and in adjacent noninflamed mucosa. A reverse-transcription polymerase chain reaction (RT-PCR) analysis was performed to confirm the results obtained by immunohistochemistry. In addition, western blot experiments were carried out.
RESULTS: CD inflamed mucosa showed higher global expression of MMP-2, MMP-9, and MMP-13 than diverticulitis inflamed mucosa. However, inflamed and noninflamed diverticulitis mucosal samples showed higher global expression of MMP-1, TIMP-1, and 3 than the CD samples. Epithelial cells of inflamed mucosa showed higher expression of MMP-2, 9, and 13 in CD than diverticulitis. However, the latter showed higher expression of TIMP-1. Similar differences for fibroblast-like cells and mononuclear inflammatory cells were found. CD samples presented an increased expression of MMPs and a decreased expression of TIMPs compared to diverticulitis.
CONCLUSIONS: These results indicate a differential pattern of expression of MMPs and TIMPs in CD and diverticulitis and the necessity to study the potential role of MMP inhibitors as new protective agents in both diseases.
Copyright © 2011 Crohn's & Colitis Foundation of America, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21438097     DOI: 10.1002/ibd.21682

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  10 in total

1.  Surgical diverticulitis is not associated with defects in the expression of wound healing genes.

Authors:  Tara M Connelly; Arthur S Berg; Leonard R Harris; Rafel Tappouni; Dave Brinton; Sue Deiling; Walter A Koltun
Journal:  Int J Colorectal Dis       Date:  2015-05-24       Impact factor: 2.571

Review 2.  Diverticular disease: changing epidemiology and management.

Authors:  Roshan Razik; Geoffrey C Nguyen
Journal:  Drugs Aging       Date:  2015-05       Impact factor: 3.923

3.  Sex and Race Disparities in Diverticulosis Prevalence.

Authors:  Anne F Peery; Temitope O Keku; Joseph A Galanko; Robert S Sandler
Journal:  Clin Gastroenterol Hepatol       Date:  2019-10-18       Impact factor: 11.382

4.  Matrix metalloproteinases cleave membrane-bound PD-L1 on CD90+ (myo-)fibroblasts in Crohn's disease and regulate Th1/Th17 cell responses.

Authors:  Jose E Aguirre; Ellen J Beswick; Carl Grim; Gabriela Uribe; Marissa Tafoya; Gabriela Chacon Palma; Von Samedi; Rohini McKee; Romain Villeger; Yuriy Fofanov; Yingzi Cong; Gregory Yochum; Walter Koltun; Don Powell; Irina V Pinchuk
Journal:  Int Immunol       Date:  2020-01-09       Impact factor: 4.823

Review 5.  Is there new hope for therapeutic matrix metalloproteinase inhibition?

Authors:  Roosmarijn E Vandenbroucke; Claude Libert
Journal:  Nat Rev Drug Discov       Date:  2014-11-07       Impact factor: 84.694

Review 6.  Epidemiology, Pathophysiology, and Treatment of Diverticulitis.

Authors:  Lisa L Strate; Arden M Morris
Journal:  Gastroenterology       Date:  2019-01-17       Impact factor: 22.682

7.  Comparison of multiple enzyme activatable near-infrared fluorescent molecular probes for detection and quantification of inflammation in murine colitis models.

Authors:  Shengli Ding; Randal E Blue; Douglas R Morgan; Pauline K Lund
Journal:  Inflamm Bowel Dis       Date:  2014-02       Impact factor: 5.325

8.  Relationship between Metalloprotease-7 and -14 and Tissue Inhibitor of Metalloprotease 1 Expression by Mucosal Stromal Cells and Colorectal Cancer Development in Inflammatory Bowel Disease.

Authors:  Antonio Altadill; Noemi Eiro; Luis O González; Alejandro Andicoechea; Silvia Fernández-Francos; Luis Rodrigo; José Luis García-Muñiz; Francisco J Vizoso
Journal:  Biomedicines       Date:  2021-04-30

Review 9.  Etiopathogenetic Mechanisms in Diverticular Disease of the Colon.

Authors:  Michael Camilleri; Robert S Sandler; Anne F Peery
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2019-07-25

Review 10.  Metalloproteinases in Inflammatory Bowel Diseases.

Authors:  Martin Marônek; Irene Marafini; Roman Gardlík; René Link; Edoardo Troncone; Giovanni Monteleone
Journal:  J Inflamm Res       Date:  2021-03-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.